Performances of 18F-FDOPA PET/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors.

Date publication

janvier 2022

Journal

Clinical nuclear medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume , Pr PAPATHANASSIOU Dimitri

Tous les auteurs :
Morland D, Jallerat P, Brixi H, Cadiot G, Papathanassiou D, Deguelte S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35067541

Résumé

Peritoneal carcinomatosis (PC) concerns up to 30% of patients with a neuroendocrine tumor (NET), especially of the small intestine. Aggressive management of carcinomatosis seems to be justified, especially with regard to possible mechanical complications. 18F-FDOPA PET/CT is known to be the most sensitive imaging modality for the detection of small bowel NET metastases, yet its performance in the detection of PC is not well studied. The main objective of our study is to evaluate the performances of preoperative 18F-FDOPA PET/CT in the prediction of surgical peritoneal cancer index.

Référence

Clin Nucl Med. 2022 Jan 21;: